BOSTON SCIENTIFIC CORP ($BSX)

7 tracked superinvestors hold BOSTON SCIENTIFIC CORP (BSX), worth $4.5B combined, led by David Shaw. Smart money is accumulating BSX as of the latest 13F filings.

Current price

$44.99

Medical - DevicesNYSEUS

-56.9%

1Y

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable…

Market cap

$84.0B

P/E

23.64

Div yield

0.0%

Revenue YoY

19.9%

Analyst target

$82

Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.

Superinvestors holding

7

tracked 13F / N-PORT funds

Combined value

$4.5B

disclosed long exposure

Tier-1 conviction

1

concentrated holders

Net this quarter

+2

4 buying · 2 selling

Smart money is net accumulating BSX: 4 funds added or opened versus 2 trimming.

The smart-money take on BSX

BOSTON SCIENTIFIC CORP (BSX) is held by 7 tracked funds worth $4.5B combined, 1 of them concentrated Tier-1 managers whose positions carry real conviction.

The largest position belongs to David Shaw at 1% of their book — no single tracked manager treats it as an outsized, top-weighted bet.

No tracked fund opened a new position this quarter; 4 added and 2 trimmed, a net add.

Superinvestors holding BSX

InvestorMove% of their portfolioPosition value
2
David Shaw

D.E. Shaw

Added1%$1.5B
3
PRIMECAP team

Vanguard PRIMECAP

Held2.1%$1.3B
2
Added0.5%$591M
3
Will Danoff

Fidelity Contrafund

Trimmed0.4%$505M
2
Added0.5%$366M
2
ex-Jim Simons

Renaissance Technologies

Added0.3%$198M
1
Stephen Mandel

Lone Pine Capital

Trimmed0.1%$7M

Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.

Frequently asked

Which superinvestors own BSX?

7 tracked funds hold BOSTON SCIENTIFIC CORP (BSX), the largest being David Shaw (D.E. Shaw) at 1% of its 13F portfolio. 1 of them are concentrated Tier-1 conviction managers.

Is smart money buying or selling BSX?

In the most recent 13F quarter, 4 tracked funds added or opened BSX and 2 trimmed it.

How much BSX do tracked funds hold?

Combined disclosed long exposure to BSX across tracked superinvestors is $4.5B as of the Mar 2026 filings.

Stocks often held alongside BSX

Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.